What is the appropriate workup for a patient with asymmetric septal hypertrophy?

Workup for Asymmetric Septal Hypertrophy

For a patient with asymmetric septal hypertrophy, transthoracic echocardiography is the cornerstone initial diagnostic test, followed by genetic testing, family screening, and exclusion of HCM mimics to establish whether this represents true hypertrophic cardiomyopathy versus secondary causes like hypertensive heart disease. 1, 2

Initial Diagnostic Evaluation

Echocardiographic Assessment

• Comprehensive transthoracic echocardiography (TTE) is mandatory as the first-line imaging modality to establish the diagnosis, quantify wall thickness, assess for left ventricular outflow tract obstruction (LVOTO), evaluate mitral regurgitation, and determine LV systolic and diastolic function 1

• Measure specific parameters including:

  • Interventricular septal thickness and posterior wall thickness to calculate the septal/posterior wall ratio (ASH defined as ratio >1.3-1.5) 3, 4, 5
  • Maximum wall thickness in any segment (≥15 mm in adults, or ≥13 mm with family history/pathogenic variant) 2
  • Left ventricular mass index 3
  • Presence and severity of dynamic LVOTO at rest 1

• If resting LVOT gradient is <50 mm Hg, perform provocative maneuvers (sustained Valsalva or squat-to-stand) during TTE to unmask dynamic obstruction 1

• For symptomatic patients without resting or provocable gradient ≥50 mm Hg, exercise TTE is recommended to detect and quantify dynamic LVOTO 1

Distinguishing HCM from Secondary Causes

A critical diagnostic challenge is differentiating true HCM from hypertensive heart disease, as hypertension coexists in 25-33% of newly diagnosed HCM patients 2

• Hypertensive heart disease typically causes:

  • Symmetric hypertrophy rather than asymmetric patterns 2, 6
  • Mild to moderate wall thickening (rarely >18 mm) 2
  • Wall thickness proportionate to hypertension severity 2

• Features favoring HCM over hypertensive heart disease:

  • Severe asymmetric hypertrophy (especially >18 mm) with mild hypertension 2
  • Apical hypertrophy with marked precordial T-wave inversions on ECG 2
  • Family history of HCM 2
  • Myocardial disarray on histopathology (if biopsy performed) 6

• Isolated basal septal hypertrophy (sigmoid septum) in elderly hypertensive patients represents a common diagnostic conundrum where distinction between benign and pathologic conditions may be unclear 2

Genetic Testing and Family Screening

• Genetic testing should be offered to all individuals with clinical diagnosis of HCM to exclude rare genetic diseases that mimic HCM and facilitate family screening 2

• Screen all first-degree relatives with TTE as part of initial family screening and periodic follow-up 1

• In families with identified pathogenic variants, offer counseling and genetic testing to all relatives regardless of age 2

• For genotype-positive, phenotype-negative individuals, perform echocardiography at intervals of:

  • Every 1-2 years in children and adolescents 1
  • Every 3-5 years in adults 1

Exclusion of HCM Mimics

Systematically evaluate for conditions that can mimic HCM, including metabolic disorders (Fabry disease, amyloidosis), neuromuscular diseases, mitochondrial disorders, and syndromic conditions, as accurate diagnosis may alter treatment (e.g., enzyme therapy for Fabry disease) 2

Follow-up Imaging

• For patients with established HCM and stable clinical status, repeat TTE every 1-2 years to assess degree of hypertrophy, dynamic LVOTO, mitral regurgitation, and myocardial function 1

• For any change in clinical status or new clinical event, perform repeat TTE promptly 1

• Consider cardiac MRI if TTE is inconclusive, particularly for apical HCM, apical aneurysms, or atypical hypertrophy patterns 1

Common Pitfalls

Do not dismiss asymmetric septal hypertrophy as simply "hypertensive heart disease" without thorough evaluation, as up to 55% of patients with severe hypertension can develop ASH 4, but this may represent true HCM requiring different management and family screening 2

Recognize that ASH can be unmasked after aortic valve replacement in patients with concurrent aortic stenosis, potentially causing persistent symptoms if not addressed 7

Avoid relying solely on history, physical examination, or ECG to detect disease in family members, as echocardiography is essential for identifying asymptomatic affected relatives 8